Sai Life Sciences Limited
| Opening Date | Closing Date | Face Value | Issue Price | Lot Size | Listing At | Total Issue Size | Basis of Allotment | Initiation of Refunds | Credit of Shares to Demat | Listing Date |
|---|---|---|---|---|---|---|---|---|---|---|
| 11-12-2024 | 13-12-2024 | ₹1 per share | 0 | 27 Shares | BSE, NSE | 17,304,189 shares (aggregating up to ₹950.00 Cr) | 2024-12-16 00:00:00 | 2024-12-17 00:00:00 | 2024-12-17 00:00:00 | 18-12-2024 |
About The Company
Sai Life Sciences IPO is a book built issue of Rs 3,042.62 crores. The issue is a combination of fresh issue of 1.73 crore shares aggregating to Rs 950.00 crores and offer for sale of 3.81 crore shares aggregating to Rs 2,092.62 crores.
Sai Life Sciences IPO opens for subscription on December 11, 2024 and closes on December 13, 2024. The allotment for the Sai Life Sciences IPO is expected to be finalized on Monday, December 16, 2024. Sai Life Sciences IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, December 18, 2024.
Sai Life Sciences IPO price band is set at ₹522 to ₹549 per share. The minimum lot size for an application is 27 Shares. The minimum amount of investment required by retail investors is ₹14,823. The minimum lot size investment for sNII is 14 lots (378 shares), amounting to ₹207,522, and for bNII, it is 68 lots (1,836 shares), amounting to ₹1,007,964.
Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd and Iifl Securities Ltd are the book running lead managers of the Sai Life Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Sai Life Sciences IPO RHP for detailed information.
IPO Subscription Status
| Category | Subscription Times |
|---|---|
| Total | 1.26 |
| Anchor Investors | 1 |
| Qualified Institutions | 3.20 |
| Non-Institutional Buyers | 0.60 |
| Retail Investors | 0.42 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | 14823 |
| Retail (Max) | 13 | 51 | 192699 |
| S-HNI (Min) | 14 | 378 | 207522 |
| S-HNI (Max) | 67 | 1809 | 993141 |
| B-HNI (Min) | 68 | 1836 | 1007964 |
IPO Listing Details
| Listing Date | 18-12-2024 |
| BSE Script Code | - |
| NSE Symbol | - |
| ISIN | - |
| Final Issue Price | 0 |
Promoter holdings
Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytrey, Sai Quest Syn Private Limited, Sunflower Partners, Lily Partners, Marigold Partners and Tulip Partners.
Contact Information of the Company
Sai Life Sciences Limited
Plot No. DS-7, IKP Knowledge Park
Turkapally Village, Shameerpet Mandal,
Malkajgiri District, Hyderabad-500078
Phone: +9140 6815 6000
Email: investors@sailife.com
Website: https://www.sailife.com/
IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sailifesciences.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Manager
Kotak Mahindra Capital Company Limited (Past IPO Performance) Jefferies India Private Limited (Past IPO Performance) Morgan Stanley India Company Pvt Ltd (Past IPO Performance) Iifl Securities Ltd (Past IPO Performance)